Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis-Reference-Cited by-同舟云学术

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

Published:2021-03 Issue:3 Volume:6 Page:185-198
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Petroff David,Blank Valentin,Newsome Philip N,Shalimar ,Voican Cosmin Sebastian,Thiele Maja,de Lédinghen Victor,Baumeler Stephan,Chan Wah Kheong,Perlemuter Gabriel,Cardoso Ana-Carolina,Aggarwal Sandeep,Sasso Magali,Eddowes Peter J,Allison Michael,Tsochatzis Emmanuel,Anstee Quentin M,Sheridan David,Cobbold Jeremy F,Naveau Sylvie,Lupsor-Platon Monica,Mueller Sebastian,Krag Aleksander,Irles-Depe Marie,Semela David,Wong Grace Lai-Hung,Wong Vincent Wai-Sun,Villela-Nogueira Cristiane A,Garg Harshit,Chazouillères Olivier,Wiegand Johannes,Karlas Thomas

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference63 articles.

1. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease;Castera;Gastroenterology,2019

2. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis;J Hepatol,2015

3. Liver Fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

5. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management;McPherson;J Hepatol,2015

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial;Medicina;2024-08-21

2. Associations of five dietary indices with metabolic dysfunction-associated steatotic liver disease and liver fibrosis among the United States population;Frontiers in Nutrition;2024-08-16

3. NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review;International Journal of Molecular Sciences;2024-08-02

4. Reference values and associated factors of controlled attenuation parameter and liver stiffness in adults: A cross-sectional study;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

5. Multiparametric Ultrasound for Chronic Liver Disease;Radiologic Clinics of North America;2024-08